We I’ll know if RLF-100 ‘s IV trial will be stopped for outstanding efficacy within 10 days ( interim analysis )
If stopped for efficacy , the drug will be approved and granted at least 3 yr market exclusivity for IV use
Your sub Q version would probably complete with the inhaled version of
RLF-100
Kiwi
Recent PHASQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:55:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:17:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 11:17:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 12:52:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 04:34:57 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/25/2023 04:31:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:21:30 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM